ScholarIQanswers from OpenAlex
Novartis (Switzerland)
InstitutionResearch output, impact & collaborations
Novartis (Switzerland) is a institution indexed in ScholarIQ from OpenAlex.
What is known about Novartis (Switzerland)?
ScholarIQrecord summary
Novartis (Switzerland) is a research organisation in Basel, CH. OpenAlex records 36,463 works and 5,710,079 citations for it. 9,312 researchers list it as their most recent affiliation.
How many works does Novartis (Switzerland) have?
ScholarIQindexed works
Novartis (Switzerland) has 36,463 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Novartis (Switzerland) have?
ScholarIQcitation count
Novartis (Switzerland) has 5,710,079 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Novartis (Switzerland)?
ScholarIQresearcher count
Novartis (Switzerland) has 9,312 researchers in the ScholarIQ index.
What is the average h-index at Novartis (Switzerland)?
ScholarIQavg h-index
Novartis (Switzerland) has an average h-index of 53.8 in OpenAlex.
What is the ROR of Novartis (Switzerland)?
ScholarIQror
The ROR for Novartis (Switzerland) is on the source record.
What is the OpenAlex record for Novartis (Switzerland)?
ScholarIQopenalex
The OpenAlex for Novartis (Switzerland) is on the source record.
Who are the most-cited researchers behind Novartis (Switzerland)?
ScholarIQtop researchers by citations
What are the most-cited papers on Novartis (Switzerland)?
ScholarIQmost cited works
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina, Giordano Caponigro, Nicolas Stransky, K. Venkatesan, Adam A. Margolin, Sung Joon Kim, Christopher J. Wilson, Joseph Lehár, Gregory V. Kryukov, Dmitriy Sonkin, Anupama Reddy, Manway Liu, Lauren Murray, Michael F. Berger, John E. Monahan, Paula Morais, Jodi Meltzer, Adam Korejwa, Judit Jané‐Valbuena, Felipa Mapa, Joseph Thibault, Eva Bric-Furlong, Pichai Raman, Aaron Shipway, Ingo H. Engels, Jill Cheng, Guoying Karen Yu, Jianjun Yu, Peter Aspesi, Melanie de Silva, Kalpana Jagtap, Michael D. Jones, Li Wang, Charlie Hatton, Emanuele Palescandolo, Supriya Gupta, Scott Mahan, Carrie Sougnez, Robert C. Onofrio, Ted Liefeld, Laura E. MacConaill, Wendy Winckler, Michael Reich, Nanxin Li, Jill P. Mesirov, Stacey Gabriel, Gad Getz, Kristin Ardlie, Vivien W. Chan, Vic E. Myer, Barbara L. Weber, Jeff Porter, Markus Warmuth, Peter M. Finan, Jennifer L. Harris, Matthew Meyerson, Todd R. Golub, Michael Morrissey, William R. Sellers, Robert Schlegel, Levi A. Garraway
Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
John J.V. McMurray, Milton Packer, Akshay S. Desai, Jianjian Gong, Martin Lefkowitz, Adel R. Rizkala, Jean L. Rouleau, Victor Shi, Scott D. Solomon, Karl Swedberg, Michael R. Zile
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
David C. Goff, Donald M. Lloyd‐Jones, Glen C. Bennett, Sean Coady, Ralph B. D’Agostino, Raymond J. Gibbons, Philip Greenland, Daniel T. Lackland, Daniel Levy, Christopher J. O’Donnell, Jennifer G. Robinson, J. Sanford Schwartz, Susan T. Shero, Sidney C. Smith, Paul D. Sorlie, Neil J. Stone, Peter W.F. Wilson
Identification and Importance of Brown Adipose Tissue in Adult Humans
Aaron M. Cypess, Sanaz Lehman, Gethin Williams, Ṭal Ilan, Dean Rodman, Allison B. Goldfine, Frank C. Kuo, Edwin L. Palmer, Yu‐Hua Tseng, Alessandro Doria, Gerald M. Kolodny, C. Ronald Kahn
Heart Disease and Stroke Statistics—2009 Update
WRITING GROUP MEMBERS, Donald M. Lloyd‐Jones, Robert J. Adams, Mercedes R. Carnethon, Giovanni de Simone, T. Bruce Ferguson, Katherine M. Flegal, Earl S. Ford, Karen L. Furie, Alan S. Go, Kurt J. Greenlund, Nancy Haase, Susan M. Hailpern, Michael Ho, Virginia J. Howard, Brett Kissela, Steven J. Kittner, Daniel T. Lackland, Lynda D. Lisabeth, Ariane Marelli, Mary Mcdermott, James B. Meigs, Dariush Mozaffarian, Graham Nichol, Christopher J. O’Donnell, Véronique L. Roger, Wayne D. Rosamond, Ralph L. Sacco, Paul D. Sorlie, Randall S. Stafford, Julia Steinberger, Thomas Thom, Sylvia Wasserthiel-Smoller, Nathan D. Wong, Judith Wylie‐Rosett, Yuling Hong
How much of the research on Novartis (Switzerland) is open access?
ScholarIQopen access share
75%OPEN ACCESS